# Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate

> **NCT01605617** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 4 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Fesoterodine fumarate
- **DRUG:** Placebo
- **PROCEDURE:** Percutaneous Tibial Nerve Stimulation (PTNS)

## Key facts

- **NCT ID:** NCT01605617
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low recruitment rate, and study patients were removed prior to completion
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605617, "Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01605617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*